Los puntos clave no están disponibles para este artículo en este momento.
Increased ovarian cancer risk in ART-treated women compared with the general population is likely explained by nulliparity rather than ART treatment. The increased risk of borderline ovarian tumors after ART must be interpreted with caution because no dose-response relationship was observed.
Spaan et al. (Tue,) studied this question.